Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:50 PM
Ignite Modification Date:
2025-12-24 @ 2:50 PM
NCT ID:
NCT05493059
Eligibility Criteria:
Inclusion Criteria:
* Mucocutaneous Leishmaniasis proven by culture and/or polymerase chain reaction (PCR)
* Seen in French Guiana between 01/01/2017 and 01/04/2022, in dispensaries (CDPS) or in the Dermatology Department of the CHC
* Having received treatment with Miltefosine
* Patient who consented to participate in the study
* Age equal or superior to 18 years
Exclusion Criteria:
* Clinically suspected but not parasitologically proven leishmaniasis
* Refusal to participate
* Age \< 18
* Patient under legal guardianship
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05493059
Study Brief:
Protocol Section:
NCT05493059